3.11.25

GBS

 Guillain-BarrĂ© syndrome (GBS)

GBS manifests as a rapidly evolving areflexic motor paralysis with or without sensory disturbance. The usual pattern is an ascending paralysis that may be first noticed as rubbery legs. Weakness typically evolves over hours to a few days and is frequently accompanied by tingling dysesthesias in the extremities. The legs are usually more affected than the arms, and facial diparesis is present in 50% of affected individuals. The lower cranial nerves are also frequently involved, causing bulbar weakness with difficulty handling secretions and maintaining an airway; the diagnosis in these patients may initially be mistaken for brain stem ischemia. Pain in the neck, shoulder, back, or diffusely over the spine is also common in the early stages of GBS.

1. The Pathophysiology

The Mistaken Attack         

The core problem in GBS is an autoimmune mix-up. The vast majority of people get GBS after recovering from a simple infection, like a stomach bug or a common cold.

  1. The Trigger: Your immune system fights the infection (say, a bug called Campylobacter jejuni).
  2. The Confusion: The immune system develops antibodies to kill the germ. Unfortunately, some parts of the germ look almost identical to the coatings on your healthy nerve cells. This is called molecular mimicry.
  3. Friendly Fire: The antibodies and immune cells now mistakenly attack your nerves.

Wiring Damage and Types

Nerves are like electrical cables. GBS damages them in two main ways, leading to different subtypes:

  • AIDP (Most Common in the West): The attack targets the myelin sheath, which is the fatty, insulating coating around the nerve wire. This is like stripping the rubber off an electrical cord—it slows the signal down or stops it entirely. This is called demyelination.
  • AMAN/AMSAN (More Common in Asia): The attack targets the axon, which is the actual copper wire inside the cable. This is often more severe because the wire itself is destroyed, leading to a longer, tougher recovery.

Types of GBS and Pathophysiological Differences

The different clinical presentations of GBS are primarily classified based on the target of the immune attack, which can be confirmed by electrodiagnostic studies:

GBS Type

Pathophysiological Target

Electrodiagnostic Finding

Geographic Prevalence

Acute Inflammatory Demyelinating Polyneuropathy (AIDP)

Myelin sheath of peripheral nerves.

Demyelination: Prolonged distal latencies, slowed conduction velocities, conduction block.

Most common in Western countries (85–90%).

Acute Motor Axonal Neuropathy (AMAN)

Axons of motor nerves.

Axonal: Low compound muscle action potential (CMAP) amplitudes with preserved sensory responses. Often associated with anti-GM1/GD1a antibodies.

More common in Asian countries (China, Mexico, Japan).

Acute Motor-Sensory Axonal Neuropathy (AMSAN)

Axons of both motor and sensory nerves.

Axonal: Low amplitude motor and sensory nerve action potentials.

Less common; generally a more severe form.

Miller Fisher Syndrome (MFS)

Predominantly cranial nerves.

Often a variant of GBS, classically associated with anti-GQ1b antibodies, which target gangliosides highly concentrated in the oculomotor, trochlear, and abducens nerves.

Rare, relatively more common in Asia.

2. Signs and Symptoms

GBS is recognized by the speed and pattern of its symptoms, which usually reach their worst point within two to four weeks.

The Typical Start and Progression

The classic sign is ascending paralysis:

  • Tingling and Numbness: It often begins as paresthesias (pins and needles) and numbness in the feet and legs.
  • Rising Weakness: The weakness starts in the legs and slowly creeps upward to the arms and face. People often report difficulty climbing stairs, walking, or getting out of a chair.
  • The Key Clue: A hallmark of GBS is the loss of your deep tendon reflexes (like the knee-jerk reflex) doctors call this areflexia.

The Major Threats

This isn't just a muscle problem; GBS is a whole-body crisis:

  • Bulbar Weakness: When the weakness hits the face and throat, it causes trouble talking (slurring) and trouble swallowing, which is very serious.
  • Autonomic Instability: The nerves that control your unconscious functions like heart rate, blood pressure, and digestion can go haywire. This can lead to dangerous swings in blood pressure and serious heart rhythm problems.
  • Respiratory Failure: The biggest risk: if the weakness reaches the diaphragm and chest muscles, the patient cannot breathe on their own and needs a ventilator (breathing machine). This happens to about 1 in 3 people.

3. Causes and Triggers

GBS isn't contagious or inherited; it's a sporadic event, almost always caused by the body's overreaction to an illness.

Common Triggers

  • Campylobacter jejuni: This is the top trigger. It's a common cause of food poisoning.
  • Viruses: Infections like CMV, EBV (Mono), Zika, and even COVID-19 have been linked to GBS.
  • Vaccines: While sometimes discussed, the risk of getting GBS from a vaccine (like the flu shot) is extremely small far, far lower than the risk of catching the illness itself and triggering GBS that way.

Who Gets It?

  • GBS can affect anyone, but it becomes more common as people get older.
  • Men are slightly more likely to be affected than women.

  • The overall chance of getting it is very low, about 1 to 2 people out of every 100,000 each year.

4. Management and Recovery

Because GBS moves so fast, time is muscle. Early diagnosis and treatment are the absolute key to a better recovery.

The Immediate Lifeline

Treatment must begin within the first two weeks of symptom onset. Doctors use treatments designed to neutralize or remove the harmful antibodies:

  1. IVIg (Intravenous Immunoglobulin): This is made from healthy donor blood that contains normal antibodies. It's given through an IV to “overwhelm” and neutralize the bad antibodies that are attacking the nerves.
  2. Plasma Exchange (PLEX): This is a procedure similar to dialysis. It involves removing the patient's blood plasma (which contains the harmful antibodies) and replacing it with healthy replacement fluid.

Both treatments work equally well to shorten the time to recovery and decrease the need for a ventilator.

Ongoing Care and Recovery

  • Intensive Monitoring: Patients are closely watched, especially for breathing problems. Doctors regularly measure lung function to catch respiratory failure before it becomes an emergency.
  • Supportive Care: Managing extreme blood pressure swings, heart issues, and severe nerve pain (which is very common) are critical during the acute phase.
  • Rehabilitation: Once the condition stabilizes, the long road to recovery begins. Physical therapy, occupational therapy, and emotional support are essential for helping patients regain strength, relearn movements, and manage the lasting fatigue or weakness.

GBS is a frightening journey, but with modern treatment and intensive rehabilitation, most people make a full or near-full recovery, though it can take months or even a year.

Rehabilitation Strategies

Recovery is often prolonged, lasting weeks to months.

  • Physical and Occupational Therapy: Started early, even during the acute phase, to maintain range of motion, prevent contractures, and address muscle weakness.
  • Neurorehabilitation: A multidisciplinary approach is required during the recovery phase to maximize functional independence, address residual deficits (such as chronic fatigue or residual weakness), and manage psychological sequelae (anxiety, depression).

The importance of early diagnosis and treatment is paramount, as prompt initiation of IVIg or PLEX within the first two weeks significantly improves the outcome, accelerates recovery, and reduces long-term disability.


 

1.11.25

Hyperbilirubinemia

 Hyperbilirubinemia: Understanding Causes, Symptoms, and Management

1. Pathophysiology

Hyperbilirubinemia refers to an excess of bilirubin in the blood. Bilirubin is a yellow pigment formed when red blood cells break down. Normally, the liver processes bilirubin and helps excrete it through bile into the digestive tract.

This process involves several steps:

  • Production: Old red blood cells are broken down in the spleen and bone marrow, releasing hemoglobin. This hemoglobin is converted into unconjugated (indirect) bilirubin, which is not water-soluble.
  • Transport: Unconjugated bilirubin binds to albumin in the blood and travels to the liver.
  • Conjugation: Inside the liver, enzymes (especially UDP-glucuronosyltransferase) convert it into conjugated (direct) bilirubin, which is water-soluble.
  • Excretion: Conjugated bilirubin is secreted into bile, enters the intestines, and is eventually eliminated in stool as stercobilin, giving stool its brown color.

Hyperbilirubinemia occurs when there’s a problem at any step too much production, poor liver processing, or obstruction of bile flow.

2. Causes

Causes of hyperbilirubinemia are generally divided into three categories based on where the problem occurs:

a. Pre-hepatic (Before the Liver)

This type results from excessive breakdown of red blood cells, overwhelming the liver’s ability to process bilirubin.
Common causes include:

  • Hemolytic anemia
  • Sickle cell disease
  • Thalassemia
  • Transfusion reactions
  • Hemolytic disease of the newborn

b. Hepatic (Within the Liver)

Here, the liver is unable to properly conjugate or excrete bilirubin due to cellular injury or enzyme deficiency.
Common causes include:

  • Viral hepatitis (A, B, C, etc.)
  • Alcoholic or non-alcoholic liver disease
  • Cirrhosis
  • Drug-induced liver injury
  • Genetic disorders (e.g., Gilbert syndrome, Crigler–Najjar syndrome)

c. Post-hepatic (After the Liver)

Also known as obstructive hyperbilirubinemia, this occurs when bile cannot drain from the liver to the intestine.
Common causes include:

  • Gallstones
  • Biliary atresia
  • Pancreatic or bile duct tumors
  • Cholestasis due to certain medications

3. Signs and Symptoms

The most recognizable sign of hyperbilirubinemia is jaundice, a yellow discoloration of the skin, sclera (white of the eyes), and mucous membranes. Other symptoms depend on the underlying cause and bilirubin levels.

Common clinical features include:

  • Yellowing of skin and eyes
  • Dark urine (due to excretion of conjugated bilirubin)
  • Pale or clay-colored stool (seen in biliary obstruction)
  • Fatigue, nausea, or loss of appetite
  • Abdominal pain or discomfort (especially in liver or gallbladder disease)
  • In severe or prolonged cases, itching (pruritus) due to bile salt accumulation

If bilirubin levels rise significantly, complications such as kernicterus (in newborns) or hepatic encephalopathy may occur.

4. Management Strategy

The main goal of treatment is to address the underlying cause of the bilirubin elevation. Management often involves a combination of supportive care, targeted therapy, and monitoring.

a. Pre-hepatic causes:

  • Treat the underlying hemolysis (e.g., corticosteroids for autoimmune hemolytic anemia).
  • Manage anemia with transfusions if needed.

b. Hepatic causes:

  • Antiviral therapy for hepatitis.
  • Avoid alcohol and hepatotoxic drugs.
  • Supportive care for liver function (adequate hydration, nutrition, and monitoring liver enzymes).
  • In inherited conditions like Gilbert syndrome, no treatment is usually required.

c. Post-hepatic causes:

  • Relieve obstruction (e.g., remove gallstones, perform ERCP, or surgical correction for tumors or strictures).
  • In infants, phototherapy, or exchange transfusion may be needed for severe neonatal jaundice.

Monitoring and Follow-up:

  • Regular liver function tests (LFTs)
  • Imaging (ultrasound, CT, or MRCP) to assess liver and biliary system
  • Avoiding triggers such as alcohol, certain drugs, or dehydration

Key Takeaway

Hyperbilirubinemia is not a disease itself but a sign of an underlying condition affecting red blood cells, liver function, or bile flow. Identifying the cause early allows for proper treatment and helps to prevent complications.

 

GBS

  Guillain-BarrĂ© syndrome (GBS) GBS manifests as a rapidly evolving areflexic motor paralysis with or without sensory disturbance. The usu...